Abdominal aortic calcification in patients with CKD

作者：Peeters Mieke J^*; van den Brand Jan A J G; van Zuilen Arjan D; Koster Yelka; Bots Michiel L; Vervloet Marc G; Blankestijn Peter J; Wetzels Jack F M

来源：Journal of Nephrology, 2017, 30(1): 109-118.

DOI：10.1007/s40620-015-0260-7

• Abdominal aortic calcification
• Cardiovascular risk
• Chronic kidney disease
• Prognosis

Background Abdominal aortic calcification (AAC) is independently associated with cardiovascular events in dialysis patients and in the general population. However, data in non-dialysis chronic kidney disease (CKD) patients are limited. We analyzed determinants and prognostic value of AAC in non-dialysis CKD patients.
Methods We included patients with CKD not receiving renal replacement therapy from the MASTERPLAN study, a randomized controlled trial that started in 2004. In the period 2008-2009, an X-ray to evaluate AAC was performed in a subgroup of patients. We studied AAC using a semi-quantitative scoring system by lateral lumbar X-ray. We used baseline and 2-year data to find determinants of AAC. We used a composite cardiovascular endpoint and propensity score matching to evaluate the prognostic value of AAC.
Results In 280 patients an X-ray was performed. In 79 patients (28 %) the X-ray showed no calcification, in 62 patients (22 %) calcification was minor (< 4), while 139 patients (50 %) had moderate or heavy calcification (>= 4). Older age, prior cardiovascular disease, higher triglyceride levels, and higher phosphate levels were independent determinants of a calcification score >= 4. AAC score >= 4 was independently associated with cardiovascular events, with a hazard ratio of 5.5 (95 % confidence interval 1.2-24.8).
Conclusions Assessment of AAC can identify CKD patients at higher cardiovascular risk, and may provide important information for personalized treatment. Whether this approach will ultimately translate into better outcomes remains to be answered.

• 出版日期2017-2